Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the
U.S IVF Services Market
Request Now !
The U.S. IVF market size was valued at $4,905.46 million in 2020, and is expected to reach $5,563.06 million by 2027, registering a CAGR of 6.8% from 2019 to 2027.
In vitro fertilization (IVF) is a technique where a woman’s eggs and man’s sperm are combined in a special laboratory to create an embryo(s). The IVF services market is anticipated to exhibit significant market growth during the forecast period, owing to rise in infertility rate, increase in trend of late pregnancies, surge in IVF success rate, and rise in disposable income in the region. IVF is one of the widely used treatments, which assisted couples with infertility problems, single mothers, and the LGBT community to procreate. Increase in infertility rate, rise in trend of delayed pregnancies, surge in IVF success rate, technological advancements in IVF treatment, growth in rate of infertility and practices of embryo banking cycles and growth in disposable income in U.S drive the growth of the IVF services market. Moreover, rise in popularity of IVF in the U.S, growth in rate of infertility and practices of embryo banking cycles, technological advancements in IVF treatment, and delayed pregnancy trends are expected to make way for the expansion of the U.S IVF services market in the future.
U.S presents productive opportunities for players operating in the IVF services market, owing to its high population base, growth in knowledge about IVF treatment, rise in popularity of IVF in the U.S, growth in rate of infertility and practices of embryo banking cycles, technological advancements in IVF treatment, and delayed pregnancy trends. According to the Centers for Disease Control and Prevention (CDC), the rate of fertilization in the age group of 35 to 39 years through IVF procedure is considerably high. In older women (more than 40 years age group), eggs produced by reproductive system are not fully formed for the process of fertilization, which result in risk of genetic disorders in the egg. Moreover, aging individuals experience a decline in production of healthy eggs and increased chance of miscarriage. Thus, increase in trend of delayed pregnancy in women is anticipated to drive growth of the IVF services market.
However, problems associated with IVF treatment such as multiple pregnancies and birth defects limit, restrictions on three-parent IVF treatments, scattered reimbursements, and high cost of IVF treatments in the U.S hinders growth of the market. In addition, the U.S. FDA has banned three-parent IVF treatments on grounds of safety toward embryos and mothers. This factor affects growth of the IVF market in the U.S. Furthermore, rise in same sex marriages pose a moderate impact on growth of the IVF services market. The demand for IVF procedures is on the rise across same sex couples, owing to high success rate. Thus, rise in same sex marriages is expected to boost the demand for IVF services.
Risein focus of key players in the U.S. is primarily set to contribute to growth of the market. The healthcare expenditure per capita is growing steadily in the region, which is expected to boost the growth. Increase in incidences of gynecological conditions, coupled with delayed pregnancy in women fuel the market. Moreover, increase in number of technological advancements of IVF procedures, along with focus and investments by major players is expected to provide several opportunities for the IVF services market growth in future. Hence, a rapid growth of the IVF services market is expected during the forecast period in the U.S.
U.s Ivf Services Market Segmentation
The U.S IVF services market is segmented on the basis of cycle type, end user, and country. By cycle type, it is divided into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. On the basis of end user, it is classified as fertility clinics, hospitals, surgical centers, and clinical research institutes.
Cycle Type segment review
By cycle type, the fresh cycle (non-donor) segment was the major revenue contributor in 2019, and accounted for 170.19 thousand cycles. This segment is expected to dominate the U.S IVF services market during the forecast period.
U.S IVF Services Market
By Cycle Type
Fresh Cycle (non-donor) segment holds a dominant position in 2019 and would continue to maintain the lead over the forecast period.
End User segment review
By end user, fertility clinics and clinical research institute play a crucial role in providing IVF treatments to couples seeking assistance for infertility treatments. The fertility clinics segment is expected to be the largest revenue-generating segment from 2019 to 2027.
U.S IVF Services Market
By End User
Fertility Clinics Segment is projected as one of the most lucrative segment.
Major companies, hospitals, surgical centers, fertility centers, and clinical research institutes are profiled in this report. The major key players included in this report are Boston IVF, Fertility and Gynecology Center Monterey Bay IVF, Conceptions Reproductive Associates, Servy Massey Fertility Institute, Sher Institute for Reproductive Medicine (SIRM), Cardone Reproductive Medicine & Infertility, Fertility Center of San Antonio, Houston Fertility Center, New hope fertility center, and Reproductive Medicine Associates of New Jersey.
Key Benefits For Stakeholders
The U.S IVF Services market share and analysis is based on a comprehensive analysis of key developments in the IVF services.
The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the U.S market.
The study provides an in-depth analysis of the market trends to elucidate the imminent investment pockets.
The U.S IVF Services market trends are studied from 2019 to 2027.
Information about key drivers, restrains, and opportunities and their impact analysis on the U.S IVF services market size is provided.
The quantitative analysis of the U.S IVF Services market from 2019 to 2027 is provided to determine the market potential.
Key Market Segments
By Cycle Type
- Fresh IVF Cycles (Non-Donor)
- Thawed IVF Cycles (Non-Donor)
- Donor Egg IVF Cycles
By End User
- Fertility Clinics
- Surgical centers
- Clinical research institutes
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.1.Market Size and forecast
3.2.2.Number of infertility clinics, 2016
3.2.3.Regulatory issues, legislations, and authorities
3.2.4.Insurance reimbursement scenario
188.8.131.52.Delayed Pregnancies in Women
184.108.40.206.Rise in popularity of IVF in the U.S.
220.127.116.11.Growth in rate of infertility and practices of embryo banking cycles
18.104.22.168.Technological advancements in IVF treatment
22.214.171.124.High cost of IVF treatments in the U.S
126.96.36.199.Restrictions on three-parent IVF treatments
188.8.131.52.Rise in Inter-Sex Marriage
3.3.5.COVID-19 Impact Analysis for IVF Market.
CHAPTER 4:U.S IVF SERVICES MARKET, BY END USER
4.1.1.Market size and forecast
4.1.2.Market size and forecast
184.108.40.206.Market Size and Forecast
220.127.116.11.Market Size and Forecast
18.104.22.168.Market Size and Forecast
4.1.6.Clinical research institutes
22.214.171.124.Market Size and Forecast
CHAPTER 5:U.S IVF SERVICES MARKET, BY CYCLE TYPE
5.1.1.Market size and forecast
5.1.2.Market volume and forecast
5.1.3.Fresh IVF cycles (non-donor)
126.96.36.199.Market Size and Forecast
5.1.4.Thawed IVF cycles (non-donor)
188.8.131.52.Market Size and Forecast
5.1.5.Donor egg IVF cycles
184.108.40.206.Market Size and Forecast
CHAPTER 6:COMPANY PROFILES
6.2.CARDONE REPRODUCTIVE MEDICINE AND INFERTILITY, LLC
6.3.CONCEPTIONS REPRODUCTIVE ASSOCIATES OF COLORADO
6.4.FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY IVF
6.5.FERTILITY CENTER OF SAN ANTONI
6.6.HOUSTON FERTILITY CENTER
6.7.NEW HOPE FERTILITY CENTER
6.8.SERVY MASSEY FERTILITY INSTITUTE
6.9.REPRODUCTIVE MEDICINE ASSOCIATES
6.10.SHER INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM)
LIST OF TABLES
TABLE 01.U.S IVF MARKET, VOLUME AND VALUE, 2019-2027 (THOUSAND AND $ MILLION)
TABLE 02.NUMBER OF FERTILITY CLINICS IN U.S (2016)
TABLE 03.ART REGULATORY SCENARIO, U.S
TABLE 04.U.S IVF SERVICES MARKET, BY END USER, 2019–2027 (THOUSAND)
TABLE 05.U.S IVF SERVICES MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 06.U.S IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2019–2027 ($MILLION)
TABLE 07.U.S IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2019–2027 (THOUSAND)
TABLE 08.BOSTON IVF BUSINESS OVERVIEW
TABLE 09.SNAPSHOT OF CARDONE REPRODUCTIVE MEDICINE AND INFERTILITY, LLC
TABLE 10.CARDONE REPRODUCTIVE MEDICINE AND INFERTILITY, LLC BUSINESS OVERVIEW
TABLE 11.SNAPSHOT OF CARDONE REPRODUCTIVE MEDICINE AND INFERTILITY, LLC
TABLE 12.CONCEPTIONS REPRODUCTIVE ASSOCIATES BUSINESS OVERVIEW
TABLE 13.SNAPSHOT OF CONCEPTIONS REPRODUCTIVE ASSOCIATES
TABLE 14.FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY IVF BUSINESS OVERVIEW
TABLE 15.SNAPSHOT OF FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY
TABLE 16.FERTILITY CENTER OF SAN ANTONI BUSINESS OVERVIEW
TABLE 17.SNAPSHOT OF FERTILITY CENTER OF SAN ANTONI
TABLE 18.HOUSTON FERTILITY CENTER BUSINESS OVERVIEW
TABLE 19.NEW HOPE FERTILITY CENTER BUSINESS OVERVIEW
TABLE 20.SNAPSHOT OF NEW HOPE FERTILITY CENTER
TABLE 21.SERVY MASSEY FERTILITY INSTITUTE BUSINESS OVERVIEW
TABLE 22.SNAPSHOT OF SERVY MASSEY FERTILITY INSTITUTE
TABLE 23.REPRODUCTIVE MEDICINE ASSOCIATES BUSINESS OVERVIEW
TABLE 24.SNAPSHOT OF REPRODUCTIVE MEDICINE ASSOCIATES
TABLE 25.SHER INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM) BUSINESS OVERVIEW
TABLE 26.SNAPSHOT OF SHER INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM)
LIST OF FIGURES
FIGURE 01.IVF SERVICES MARKET SEGMENTATION
FIGURE 02.IMPACT ANALYSES, IVF SERVICES MARKET
FIGURE 03.U.S IVF SERVIVES MARKET FOR FERTILITY CLINICS, VOLUME AND VALUE, 2019-2027, (THOUSAND, $MILLION)
FIGURE 04.U.S IVF SERVICES MARKET FOR BY HOSPITALS, VOLUME AND VALUE, 2019-2027, (THOUSAND, $MILLION)
FIGURE 05.U.S IVF SERVICES MARKET FOR SURGICAL CENTERS, VOLUME AND VALUE, 2019-2027, (THOUSAND, $MILLION)
FIGURE 06.U.S IVF SERVICES MARKET FOR CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2019-2027, (THOUSAND, $MILLION)
FIGURE 07.U.S IVF SERVICES MARKET FOR FRESH IVF CYCLES, VOLUME AND VALUE, 2019-2027, (THOUSAND, $MILLION)
FIGURE 08.U.S IVF SERVICES MARKET FOR THAWED IVF CYCLES, VOLUME AND VALUE, 2019-2027, (THOUSAND, $MILLION)
FIGURE 09.U.S IVF SERVICES MARKET FOR DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2019-2027, (THOUSAND, $MILLION)